Join GADA Canada and the John Ritter Foundation in a joint webinar featuring Dr. Shaine Morris, Pediatric Cardiologist, who will address important considerations when diagnosing and managing aortic disease in children.

Aortic dilation is a key feature in heritable aortic disease that requires timely diagnosis, treatment and management. Recent adult guidelines published by the American Heart Association and American College of Cardiology (AHA/ACC) recommend genetic testing and detailed screening when considering preventive surgical treatment and medical management of heritable aortic diseases. There are currently no consensus pediatric guidelines.

Dr. Morris will provide insights on the latest clinical information and research findings to guide the diagnosis and management of heritable aortic disease in children and young adults. The webinar is free, and registration is required. Join us on May 22, 2024 at 3:00pm EST.

ABOUT THE SPEAKERS:

Dr. Shaine A. Morris, MD, MPH
Texas Children’s Hospital (TCH)/Baylor College of Medicine (BCM), Houston, Texas

Shaine A. Morris, MD, MPH, is pediatric cardiologist at Texas Children’s Hospital (TCH)/Baylor College of Medicine (BCM) in Houston, Texas. She has completed additional advanced cardiovascular imaging training at Boston Children’s Hospital and a Master of Public Health at Harvard School of Public Health. At TCH/BCM, Dr. Morris currently serves as the Medical Director of the Cardiovascular Genetics Program and Medical Director of the Fetal Cardiology Program. She uses her combined training in cardiovascular imaging and clinical research design and analysis to lead and collaborate in outcome-based research studies focusing on pediatric aortopathy, including connective tissue disorders like Loeys-Dietz syndrome and Marfan syndrome. She also leads the multi-center aortopathy registry focused on aortopathy in the young, the Collaborative for Longitudinal Aortic Research In The Young (CLARITY). Dr. Morris is on the Steering Committee of the Montalcino Aortic Consortium, facilitating the collaboration of pediatric research for gene-based precision medicine.

EVENT DISCLAIMER: The contents of this GADA Canada hosted virtual event, such as presentations, discussions, text, graphics, images, and other materials created or presented by GADA Canada and by others appearing in the event at the invitation of GADA Canada are for educational and informational purposes only. GADA Canada is a voluntary health organization and is not engaged in rendering medical advice or recommendations on diagnosis or treatment of genetic aortic disorders. The content within this virtual event or the GADA website, www.gadacanada.ca, should not replace necessary consultations with qualified health care professionals for medical advice, diagnosis, or treatment.

Genetic aortic disorders are complex, multi-system disorders that can only be properly diagnosed and managed by skilled and trained health care professionals. The manifestations and severity of these disorders vary greatly among individuals and require personalized medical management. None of the medications, courses of treatment or lifestyle & activity recommendations discussed in this virtual event should be undertaken without being discussed with your physician.